NMRA NEUMORA THERAPEUTICS INC
Health Care · Russell 2000
Next earnings: not announced yet
What 10 analyst firms say about NEUMORA THERAPEUTICS INC: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
9 rated views · 10 analyst/firm records · 10 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Fewer than 4 price targets in the last 6 months (3)
- Russell 2000 · Safest consensus · 6MNot scored · Fewer than 4 price targets in the last 6 months (3)
Recent analyst activity · last 90 days
Our tracked history has 2 reports on NMRA from 2 analyst firms in the last 90 days (10 firms in the past year).
No firm's latest available rating differs from its previous one.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Guggenheim | Yastin Suneja | Buy | 31 Mar 2026 | 14.00 USD |
| H.C. Wainwright | Douglas Tsao | Buy | 28 Jul 2026 | 7.00 USD · 27 Jul 2026 |
| Leerink Partners | Marc Goodman | Buy | 22 Apr 2026 | 5.00 USD |
| Mizuho | Graig Suvannavejh | Buy | 17 Aug 2026 | Conflicting reports · excluded |
| Needham | Ami Fadia | Buy | 16 Jun 2026 | 5.00 USD |
| RBC Capital Markets | Brian Abrahams | Buy | 13 Jul 2026 | 5.00 USD |
| Stifel | Paul Matteis | Hold | 17 Nov 2025 | 3.00 USD |
| Weiss Ratings | Unnamed analyst | — | 25 Sep 2026 | — |
| William Blair | Myles R Minter | Buy | 15 Jun 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 03:44 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.